Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medclair ABNGM:MCLR -2.24%67 Days Payable is 66.04 as of Mar. 2026, which is 49% below its 10-year median of 129.36. GuruFocus rates NGM:MCLR with a GF Score™ of 67/100 and a GF Value™ of kr2.35 (Modestly Overvalued). Among 795 Medical Devices & Instruments companies, Medclair AB ranks better than 59.75% on this metric.
Medclair AB's average Accounts Payable for the
three
months ended in Mar. 2026 was kr3.72 Mil. Medclair AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was kr5.14 Mil.
Hence, Medclair AB's Days Payable for the
three
months ended in Mar. 2026 was 66.04.
The historical rank and industry rank for Medclair AB's Days Payable or its related term are showing as below:
NGM:MCLR'
s Days Payable Range Over the Past 10 Years
Min: 36.25 Med: 129.36 Max: 383.94
Current: 86.43
During the past 11 years, Medclair AB's highest Days Payable was 383.94. The lowest was 36.25. And the median was 129.36.
NGM:MCLR's Days Payable is ranked better than 59.75% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs NGM:MCLR: 86.43
Medclair AB's Days Payable
declined
from Mar. 2025 (123.97) to Mar. 2026 (66.04).
It may suggest that Medclair ABaccelerated paying its suppliers.
Medclair AB Days Payable Related Terms
Medclair AB Days Payable Historical Data
* Premium members only.
The historical data trend for Medclair AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NGM:MCLR vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Medclair AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medclair AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medclair AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Medclair AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medclair AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medclair AB (NGM:MCLR) has a Days Payable of 66.04 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medclair AB and its competitors. This is 49% below median its historical median of 129.36. Over the past decade, Medclair AB's Days Payable has ranged from 36.25 to 383.94. According to the industry distribution chart, Medclair AB ranks #320 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 40.3%.
Is Medclair AB's Days Payable too high?
Medclair AB's current Days Payable of 66.04 is 49% below median its 10-year median of 129.36. Over the past 10 years, this metric has ranged from a low of 36.25 to a high of 383.94. The Medical Devices & Instruments industry median Days Payable is 67.87. Medclair AB's value of 66.04 is 2.7% below this industry median. Based on the distribution chart, Medclair AB ranks #320 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medclair AB has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medclair AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medclair AB ranks #320 out of 795 companies for Days Payable. This puts Medclair AB in the upper half of its industry. The industry median Days Payable is 67.87. Medclair AB's value of 66.04 is 2.7% below this benchmark. Historically, Medclair AB's own Days Payable has ranged from 36.25 to 383.94 over the past decade. While the company's 10-year median is 129.36 vs. the industry median of 67.87, Medclair AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medclair AB's current Days Payable of 66.04 is 2.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medclair AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medclair AB's current Days Payable is 66.04, which is 49% below median its own 10-year median of 129.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medclair AB stock overvalued right now?
Based on GuruFocus' analysis, Medclair AB (NGM:MCLR) is currently considered Modestly Overvalued. The stock's GF Value™ is kr2.35, compared to a current price of kr3.05 — trading 29.8% above its estimated fair value. The current Days Payable is 66.04, which is 49% below median its 10-year median of 129.36 and 2.7% below the Medical Devices & Instruments industry median of 67.87. Medclair AB's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medclair AB (NGM:MCLR), the current Days Payable is 66.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medclair AB (NGM:MCLR) Overvalued in 2026?
Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued.
The current stock price of kr3.05 is trading 29.8% above its estimated GF Value™ of kr2.35.
GuruFocus considers Medclair AB to be Modestly Overvalued.
Key valuation signals for NGM:MCLR:
Days Payable: 66.04 (49% below median its 10-year median of 129.36)
GF Value™: kr2.35 vs. price of kr3.05 (29.8% above fair value)
Industry Position: 2.7% below the Medical Devices & Instruments median (#320 of 795)
No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
67GF Score
Get the complete analysis for NGM:MCLR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGM:MCLR has been successfully added to your 
